Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronique Dartois

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Frontiers in Microbiology|June 29, 2019
Editorial: NTM-The New Uber-BugsVeronique Dartois, Christine Sizemore, Thomas Dick
Journal of the American Society for Mass Spectrometry|September 29, 2011
Reagent precoated targets for rapid in-tissue derivatization of the anti-tuberculosis drug isoniazid followed by MALDI imaging mass spectrometryM Lisa Manier, Michelle L Reyzer, Anne Goh, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 6, 2016
Development and validation of LC-ESI-MS/MS method for analysis of moxifloxacin and levofloxacin in serum of multidrug-resistant tuberculosis patients: Potential application as therapeutic drug monitoring tool in medical diagnosisSung Joong Lee, Kebede Taye Desta, Seok Yong Eum, et al.
Plos Pathogens|September 28, 2011
Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungsSelvakumar Subbian, Liana Tsenova, Paul O'Brien, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2012
Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaquesPhilana Ling Lin, Veronique Dartois, Paul J Johnston, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 30, 2019
Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infectionsBrandon Banaschewski, Deepshikha Verma, Lian J Pennings, et al.
Tuberculosis (Edinburgh, Scotland)|September 4, 2012
Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosisScott G Franzblau, Mary Ann DeGroote, Sang Hyun Cho, et al.
Antimicrobial Agents and Chemotherapy|March 22, 2022
Novel Regimens of Bedaquiline-Pyrazinamide Combined with Moxifloxacin, Rifabutin, Delamanid and/or OPC-167832 in Murine Tuberculosis ModelsRokeya Tasneen, Andrew Garcia, Paul J Converse, et al.
European Journal of Medicinal Chemistry|February 26, 2022
Synthesis and biological evaluation of orally active prodrugs and analogs of para-aminosalicylic acid (PAS)Pooja V Hegde, Michael D Howe, Matthew D Zimmerman, et al.
Plos Pathogens|April 27, 2018
Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosisYitian Xu, Lihua Wang, Matthew D Zimmerman, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Frontiers in Microbiology|June 29, 2019
Editorial: NTM-The New Uber-BugsVeronique Dartois, Christine Sizemore, Thomas Dick
Journal of the American Society for Mass Spectrometry|September 29, 2011
Reagent precoated targets for rapid in-tissue derivatization of the anti-tuberculosis drug isoniazid followed by MALDI imaging mass spectrometryM Lisa Manier, Michelle L Reyzer, Anne Goh, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 6, 2016
Development and validation of LC-ESI-MS/MS method for analysis of moxifloxacin and levofloxacin in serum of multidrug-resistant tuberculosis patients: Potential application as therapeutic drug monitoring tool in medical diagnosisSung Joong Lee, Kebede Taye Desta, Seok Yong Eum, et al.
Plos Pathogens|September 28, 2011
Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungsSelvakumar Subbian, Liana Tsenova, Paul O'Brien, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2012
Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaquesPhilana Ling Lin, Veronique Dartois, Paul J Johnston, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 30, 2019
Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infectionsBrandon Banaschewski, Deepshikha Verma, Lian J Pennings, et al.
Tuberculosis (Edinburgh, Scotland)|September 4, 2012
Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosisScott G Franzblau, Mary Ann DeGroote, Sang Hyun Cho, et al.
Antimicrobial Agents and Chemotherapy|March 22, 2022
Novel Regimens of Bedaquiline-Pyrazinamide Combined with Moxifloxacin, Rifabutin, Delamanid and/or OPC-167832 in Murine Tuberculosis ModelsRokeya Tasneen, Andrew Garcia, Paul J Converse, et al.
European Journal of Medicinal Chemistry|February 26, 2022
Synthesis and biological evaluation of orally active prodrugs and analogs of para-aminosalicylic acid (PAS)Pooja V Hegde, Michael D Howe, Matthew D Zimmerman, et al.
Plos Pathogens|April 27, 2018
Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosisYitian Xu, Lihua Wang, Matthew D Zimmerman, et al.
Pageof 4